Article Name Predictive Diagnostics
Paige’s collaboration with Microsoft in AI-driven technology for propelling cancer diagnosis forward
23rd July, 2024
To enhance Bone Marrow Transplantation outcome efficiencies in patients with hematological disorders
24th July, 2024
Demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw
02nd July, 2024
System can help in reducing the risk of hypothermia in hemorrhaging patients
07th June, 2024
For Total, Partial, and Revision Knee Arthroplasty
14th May, 2024
Expands into Japan through Mediford Corporation partnership with Precivity blood testing for Alzheimer’s Disease and brain research market
30th April, 2024
The collaboration will see Sehgal Path Lab rebranded as Neuberg Sehgal Path Lab
29th April, 2024
Developing new cost-effective detection technologies for volatile organic compounds (VOCs)
25th April, 2024
The therapies can reach patients in Europe, India and the African continent
12th April, 2024
Allowing diagnostic information to easily be available straight on the phone by simply using an app
28th March, 2024
Cognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors
20th March, 2024
First company in the country to launch the enhanced neonatal feeding system
18th March, 2024
Johnson & Johnson QuickPitch finalists revealed in atopic advancements
13th March, 2024
Bowtie and CUHK Hospital Unveil Innovative Medical Insurance + Health Package
11th March, 2024
The oncology market in India is steadily growing, driven by an increasing cancer incidence and a strong demand for advanced treatments. However, there remains substantial untapped potential, primarily in improving access to cutting-edge therapies and expanding reach to underserved regions. Glenmark Pharma, with its patient-centric approach and innovative solutions, has been steadily increasing its market share by introducing high-quality and affordable cancer drugs. Alok Malik, President & Business Head - India Formulations, Glenmark Pharmaceuticals Ltd, in an exclusive interview with MedTech Spectrum & BioSpectrum, spoke at length about the company’s mission to enhance access to high-quality cancer care in India and the untapped market potential, new launches and the plans ahead.
28th February, 2024
GALI™ SonR® CRT-D and NAVIGO™ 4LV Pacing Leads Launch Set to Enhance Heart Failure Management and Patient Safety
19th February, 2024
Transforming the Lives of 1 Lakh Preterm Infants in India through Innovative Healthcare Solutions
30th January, 2024
Care is becoming more personalized. Innovation cycles are growing shorter and shorter. Healthcare companies are increasingly looking for ways to eliminate waste and complexity. These are only a few of the reasons why 3D printing has become such an invaluable tool for MedTech research and design teams. 3D printing can make the impractical a reality. It can help providers customize devices to meet the unique care needs of individual patients almost immediately. It’s now even possible to 3D print medicine and simulated body parts.
30th January, 2024
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer